Dabigatran example sentences

"Dabigatran" Example Sentences

1. The physician prescribed dabigatran to reduce the risk of stroke.
2. Dabigatran's efficacy is well-documented in clinical trials.
3. He was concerned about the potential bleeding risks associated with dabigatran.
4. The patient experienced an adverse reaction after starting dabigatran therapy.
5. Monitoring is crucial during dabigatran treatment.
6. Dabigatran is a direct thrombin inhibitor.
7. Studies compare dabigatran to warfarin.
8. The pharmacist explained the dosage instructions for dabigatran.
9. She needed to check for drug interactions with dabigatran.
10. Unexpected bleeding was a side effect of dabigatran.
11. Regular blood tests are recommended while taking dabigatran.
12. The cost of dabigatran can be substantial.
13. Dabigatran is available in different strengths.
14. He questioned the necessity of using dabigatran for his condition.
15. Proper administration of dabigatran is paramount.
16. Research continues into the long-term effects of dabigatran.
17. Are there any alternatives to dabigatran?
18. With dabigatran, consistent dosage is key.
19. The patient's response to dabigatran was carefully monitored.
20. What are the potential complications of dabigatran?
21. Dabigatran mechanism of action involves direct thrombin inhibition.
22. Understanding the risks and benefits of dabigatran is crucial.
23. They discussed the pros and cons of dabigatran versus warfarin.
24. His recovery was attributed to the timely administration of dabigatran.
25. The medication regimen included dabigatran and aspirin.
26. She meticulously recorded her dabigatran intake.
27. Dabigatran might not be suitable for all patients.
28. Concerns about renal function arose during dabigatran therapy.
29. Before prescribing dabigatran, a thorough assessment is required.
30. The effectiveness of dabigatran varies between individuals.
31. Dabigatran is a relatively new anticoagulant.
32. Adverse events associated with dabigatran are closely monitored.
33. He stopped taking dabigatran due to severe side effects.
34. The study highlighted the importance of careful dabigatran dose adjustment.
35. Many factors influence the optimal dosage of dabigatran.
36. The patient's bleeding stopped after discontinuing dabigatran.
37. Dabigatran requires careful monitoring of kidney function.
38. Long-term use of dabigatran may necessitate regular check-ups.
39. Discontinuing dabigatran must be done under medical supervision.
40. The guidelines provided recommendations for dabigatran usage.
41. They investigated the mechanism of action of dabigatran.
42. Dabigatran is not suitable for everyone.
43. The doctor reviewed the risks and benefits of dabigatran with the patient.
44. Careful consideration is needed when prescribing dabigatran to elderly patients.
45. The pharmacokinetics of dabigatran are well-understood.
46. Dabigatran's bioavailability is influenced by various factors.
47. He felt a sense of relief after starting dabigatran treatment.
48. The clinical trial showed dabigatran to be effective in reducing clotting.
49. Proper storage of dabigatran is crucial to maintaining its efficacy.
50. Dabigatran, while effective, carries inherent risks.